Hoerger, Thomas J.

Projection of Diabetes Burden Through 2050

Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J. (2001) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 1,004

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine

Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management

Cited by 703

The Future Burden of CKD in the United States: A Simulation Model for the CDC CKD Initiative

Hoerger, T. J., Simpson, S. A., Yarnoff, B. O., Pavkov, M. E., Ríos Burrows, N., Saydah, S. H., Williams, D. E., & Zhuo, X. (2015) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 299

Screening for type 2 diabetes mellitus: a cost-effectiveness analysis

Hoerger, T. J., Harris, R., Hicks, K. A., Donahue, K., Sorensen, S., & Engelgau, M. (2004) · Annals of Internal Medicine

Health Systems, Economic Evaluations, Quality of LifeHealth Promotion and Cardiovascular Prevention

Cited by 178

Cost-Effectiveness of Bariatric Surgery for Severely Obese Adults With Diabetes

Hoerger, T. J., Zhang, P., Segel, J. E., Kahn, H. S., Barker, L. E., & Couper, S. (2010) · Diabetes Care

Bariatric Surgery and OutcomesHealth Systems, Economic Evaluations, Quality of Life

Cited by 163

A Nationwide Community-Based Lifestyle Program Could Delay Or Prevent Type 2 Diabetes Cases And Save $5.7 Billion In 25 Years

Zhuo, X., Zhang, P., Gregg, E. W., Barker, L., Hoerger, T. J., Pearson-Clarke, T., & Albright, A. (2012) · Health Affairs

Health Systems, Economic Evaluations, Quality of LifeHealth Promotion and Cardiovascular Prevention

Cited by 82

The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease

Initiative, O. B. O. T. C. F. D. C. A. P. C., Yarnoff, B. O., Hoerger, T. J., Simpson, S. K., Leib, A., Burrows, N. R., Shrestha, S. S., & Pavkov, M. E. (2017) · BMC Nephrology

Health Systems, Economic Evaluations, Quality of LifeChronic Kidney Disease and Diabetes

Cited by 55

Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.

Barbosa, C., Fraser, H., Hoerger, T. J., Leib, A., Havens, J. R., Young, A., Kral, A., Page, K., Evans, J., Zibbell, J., et al. (2019) · Addiction

HIV, Drug Use, Sexual RiskHepatitis C virus research

Cited by 48